Navigation Links
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions

cial analysts to discuss this news release today at 8:30 a.m., EST. A simultaneous webcast of the call for interested investors and others may be accessed by visiting the Johnson & Johnson website at www.investor.jnj.com. A replay and podcast will be available approximately two hours after the live webcast by visiting www.investor.jnj.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections reflected in this press release. Risks and uncertainties include general industry conditions and competition; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov or on request from Johnson & Johnson or Conor Medsystems, LLC. Neither Johnson & Johnson nor Conor Medsystems undertakes to update any forward-looking statements as a result of new information or future events or developments.)

CONTACT: media, Christopher Allman, +1-305-586-6024; investor, LouiseMehrotra, +1-732-524-6491; Stan Panasewicz, +1-732-524-2524; LesleyFishman, +1-732-524-3922

Web site: '"/>




Page: 1 2 3 4

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:7/3/2015)... HUATULCO , Mexique, July 3, 2015 /PRNewswire/ ... médicale continue cible les épidémies que sont l,hypertension, ... latine, par l,intermédiaire de plateformes éducatives gratuites et ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... le diabète en ligne , Prendre en ...
(Date:7/3/2015)... , July 3, 2015 ... heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige ... erworben zu haben. Mit dieser Übernahme dringt ... mit einem Umsatz von 765 Mrd. RUB ... Pharmamärkten der Welt gehörte (IMS Health). Seit ...
(Date:7/3/2015)... , July 3, 2015 ... with Broda Technologies Co., Ltd., operating in both the ... the company,s proprietary IntelliGel ® supramolecular hydrogel technology ... development and other ophthalmic therapies. The Broda technology offers ... solution is a free-forming liquid and with low concentrations ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2
... Feb. 20 Health Secretary Everette ... nearly $18 million will be awarded from Pennsylvania,s ... competitive grants focus on specific research priorities established ... Advisory Committee, chaired by Secretary James. The priorities ...
... published in New England Journal of Medicine employs Quest ... Testing of blood specimens may detect abnormal white ... of lymphocytic leukemia (CLL) develops, according to research published ... Journal of Medicine . The finding may ...
Cached Medicine Technology:Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 2Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 4Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 2Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 3Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis 4
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top ... mesothelioma with even minimal asbestos exposure. Click here to read the complete story ... of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed mice ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Smoothies are ... is a good blender and easily accessible, quality ingredients. Aurora Natural is proud to ... for an added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is ...
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and expose popular lies regarding proper relationships according to the bible. , ... the core of the subject by explaining why certain types of sexual relationships are ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce ... 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt chain ... 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is located ...
(Date:7/2/2015)... , ... July 02, 2015 , ... With summer in full swing, Americans are flocking ... one of the top spots for fishing in the world, and it’s easy to understand ... Ontario, Canada has great fish. , Recreational fishing is a huge industry, and Americans ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... have explained that on altering the immune cells and ... therapeutic treatment for AIDS. // ,Researchers from ... of the belief that if patients with HIV, subject ... boot camp, it could help in their fight against ...
... men, according to a new study. Dr Helen Leonard of ... Child Health Research // said the finding meant that genetic ... important. ,"The common thinking in the past had ... genetic flaw would be so serious in boys that they ...
... all set to release a new CD-ROM collects and refines ... for HIV Information at the University of California, San Francisco, ... contain more than 40 selected chapters from the HIV InSite ... HIV information that is widely respected as one of the ...
... loaded in fast foods, which deserve to go off the ... who are negatively influenced by their advertised benefits to health. ... the promotional campaigns for unhealthy foods are off the air ... about healthy diets ., According to Professor Tess van der ...
... and appropriate IT may be a far more effective ... nurses than recruiting more staff,// according to an article ... against reforming the NHS blame problems on a lack ... the “greedy” private sector. But there is evidence that ...
... show a tendency of waning as we age, but this ... ,The positive influence of exercise on cognitive ... most often substantiated by scientists, who also say that even ... chances of dementia in later life. ,While ...
Cached Medicine News:Health News:Activated T-Cells Could Help In The Battle Against HIV 2Health News:Activated T-Cells Could Help In The Battle Against HIV 3Health News:Rett Syndrome In Men? 2Health News:A Comprehensive CD-ROM On HIV/AIDS Released By Center for HIV Information 2Health News:More and Better Management Is Key to Fixing the NHS 2
... New advancements in diamond technology allow ... used at a more economical cost. Proven ... healing, and insures a superior postoperative result. ... available in a variety of widths and ...
... Toyos Aqua-Chopper, Is Used In The Subordinate ... Aqualase Cataract Removal As Well As Standard ... Allows Easy Manipulation At The Incision Site Without ... Safe Sweeping Of Nuclear Material Away From ...
... Gauge Measures 360 Degrees & Can Be Set ... Cornea. 7mm Inner Diameter & 14mm Outer Diameter ... Astigmatism Gauge That Can Be Set For AKs, ... Around The Globe., ,Marks Single Or Paired AKs, ...
... Reversible Speculums Designed To Rest Either ... The Speculums Over, Allowing Eyelids To ... To The Widest Possible Aperture., ,Open ... Unobstructed Around-The-Clock Access To The Globe ...
Medicine Products: